Position in JNJ
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$7,161,954
+$562,074 QoQ
Shares Held
28,200
+4.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.64%
of 13F equity value
Holder Rank
#1,325
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PKO Investment Management Joint-Stock Co holds $45,805,043 across 9 Drug Manufacturers - General names. JNJ ranks #3 (15.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
8,750 | $10,495,013 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
58,500 | $7,390,890 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
28,200 | $7,161,954 | |
| 4 | AMGN |
Amgen Inc
|
16,400 | $5,938,768 | |
| 5 | ABBV |
AbbVie Inc.
|
21,200 | $5,334,768 | |
| 6 | PFE |
Pfizer Inc
|
166,450 | $4,008,116 | |
| 7 | MRK |
Merck & Co., Inc.
|
30,000 | $3,855,000 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
21,000 | $1,210,020 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,161,954 | 28,200 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $6,599,880 | 27,000 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $5,794,600 | 28,000 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $8,371,898 | 45,151 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $7,202,315 | 47,151 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $4,063,080 | 24,500 | Shares | Sole | 2025-04-18 | |
| 2024-12-31 | $3,470,880 | 24,000 | Shares | Sole | 2025-03-13 | |
| 2024-09-30 | $3,241,200 | 20,000 | Shares | Sole | 2025-03-13 | |
| 2024-06-30 | $4,677,120 | 32,000 | Shares | Sole | 2025-03-13 | |
| 2024-03-31 | $4,745,700 | 30,000 | Shares | Sole | 2025-03-13 | |
| 2023-12-31 | $4,858,940 | 31,000 | Shares | Sole | 2025-03-13 | |
| 2023-09-30 | $5,540,650 | 35,574 | Shares | Sole | 2025-03-13 | |
| 2023-06-30 | $6,467,528 | 39,074 | Shares | Sole | 2025-03-13 | |
| 2023-03-31 | $16,092,720 | 103,824 | Shares | Sole | 2025-03-13 | |
| 2022-12-31 | $5,842,522 | 33,074 | Shares | Sole | 2025-03-13 | |
| 2022-09-30 | $5,484,648 | 33,574 | Shares | Sole | 2025-03-13 | |
| 2022-06-30 | $7,632,219 | 42,996 | Shares | Sole | 2025-03-13 | |
| 2022-03-31 | $6,911,261 | 38,996 | Shares | Sole | 2025-03-13 | |
| 2021-12-31 | $8,809,420 | 51,496 | Shares | Sole | 2025-03-13 | |
| 2021-09-30 | $9,690,161 | 60,001 | Shares | Sole | 2025-03-13 | |
| 2021-06-30 | $7,905,707 | 47,989 | Shares | Sole | 2025-03-13 | |
| 2021-03-31 | $5,148,263 | 31,325 | Shares | Sole | 2025-03-13 | |
| 2020-12-31 | $3,344,954 | 21,254 | Shares | Sole | 2025-03-13 | |
| 2020-09-30 | $3,164,295 | 21,254 | Shares | Sole | 2025-03-13 | |
| 2020-06-30 | $2,988,950 | 21,254 | Shares | Sole | 2025-03-13 | |
| 2020-03-31 | $1,699,969 | 12,964 | Shares | Sole | 2025-03-13 | |
| No filing history on record for this holder in this stock. | ||||||